News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
185 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17678)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (244)
2 (297)
3 (283)
4 (339)
5 (117)
6 (2)
7 (10)
8 (276)
9 (272)
10 (235)
11 (303)
12 (110)
13 (2)
14 (3)
15 (218)
16 (173)
17 (185)
18 (189)
19 (117)
21 (4)
22 (161)
23 (232)
24 (193)
25 (188)
26 (72)
27 (3)
28 (5)
29 (171)
30 (179)
31 (179)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
21
22
23
24
25
26
27
28
29
30
31
Biotech Beach
EDWARDS PASCAL PRECISION TRANSCATHETER MITRAL AND TRICUSPID VALVE REPAIR SYSTEM RECEIVES CE MARK
Edwards Lifesciences Corporation (NYSE: EW), today announced the company’s PASCAL Precision transcatheter valve repair system received CE Mark for the treatment of mitral and tricuspid regurgitation (MR and TR).
August 17, 2022
·
3 min read
BioMidwest
Experience the JUVÉDERM® Difference with Allergan Aesthetics
Allergan Aesthetics, an AbbVie company, invites consumers to experience the JUVÉDERM® difference.
August 17, 2022
·
11 min read
Biotech Bay
Karkinos Healthcare Engages OptraSCAN® Digital Pathology In its Mission of Personalized Cancer Care
OptraSCAN®, a leading end-to-end digital pathology solution provider, announced that Karkinos Healthcare has begun using the high-performance OptraSCAN Digital pathology platform to enhance care for their patient population.
August 17, 2022
·
3 min read
Genetown
Analysis Group Announces Study Using Real-World Evidence to Support Blueprint Medicines’ AYVAKYT® (avapritinib) Label Expansion for Advanced Systemic Mastocytosis in Europe
Analysis Group, announced that a study it coauthored helped support Blueprint Medicines’ label expansion of AYVAKYT® (avapritinib) to include monotherapy for the treatment of adult patients with advanced systemic mastocytosis (AdvSM), after at least one systemic therapy, in Europe.
August 17, 2022
·
4 min read
Biotech Bay
PayZen Announces SOC 2 Type II Certification
PayZen, a mission-driven fintech company delivering healthcare’s Patient Affordability Platform, today announced that they have attained Service Organization Control (SOC) 2 Type II Certification.
August 17, 2022
·
3 min read
Genetown
Cellarity Releases Novel, Open-Source, Single-Cell Dataset and Invites the Machine Learning and Computational Biology Communities to Develop New Algorithms Capable of Learning Fundamental Rules of Cell Behavior
Cellarity, a life sciences company founded by Flagship Pioneering to transform the way medicines are created, announced today the release of a unique single-cell dataset to accelerate innovation in mapping multimodal genetic information across cell states and over time.
August 17, 2022
·
6 min read
BioSig’s Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022 Leading Medical Center of Excellence Physician will discuss integrating the PURE EP™ System into their practice and procedural workflow
BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today announced its participation in the Kansas City Heart Rhythm Symposium, being held on August 20-21, 2022.
August 17, 2022
·
5 min read
Pharm Country
QPharma Launches Ti OrderPoint 2—a next-generation direct-to-rep solution
QPharma, the leading provider of cloud-based compliance solutions, today launched the next version of Ti OrderPoint®, a next-generation direct-to-rep (DTR) solution.
August 17, 2022
·
3 min read
Jumo Health Celebrates Ranking on the 2022 Inc. 5000 List of Fastest Growing Companies
Jumo Health, a global provider of age appropriate, culturally sensitive medical education resources, today announced it is among the fastest growing private companies as reported by Inc. Magazine in its prestigious Inc. 5000 list.
August 17, 2022
·
3 min read
MustGrow Biologics and Sumitomo Corporation Announce Extension of Exclusive Agreement and Program Advancement
Sumitomo Corporation has signed an extension to their Exclusive Evaluation and Option Agreement (the “Extension Agreement”) to continue developing MustGrow’s mustard-based technology across the Americas.
August 17, 2022
·
7 min read
Previous
9 of 19
Next